(FM) Oncología
Departamento académico
![Foto de (FM) Oncología](/img/uploaded/1575D5546D141A10EB89AE669C8B8533.jpg)
![Foto de UCLA Medical Center](/img/noimage_org.png)
UCLA Medical Center
Santa Mónica, Estados UnidosPublicaciones en colaboración con investigadores/as de UCLA Medical Center (2)
2023
-
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Nature Communications, Vol. 14, Núm. 1
2021
-
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 779-789